# Momentum Venture

> Momentum Venture is a VC fund in Beijing backing Biotechnology, Genetics and Therapeutics. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 5
- Last investment: Sep 2022
- Lead investor: 20%
- Last updated: Aug 2026

Momentum Venture is a VC fund in Beijing focused on Biotechnology and Genetics. Beijing Momentum Venture Management is a private fund focusing on life and health industry. Its fund investors include multiple industrial listed companies and outstanding investment institutions such as Getein Biotech, Nanjing Iron & Steel, and Nanjing Jiangbei New Area Sci-tech.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $5M–$61M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 60% |
| Genetics | 2 | 40% |
| Therapeutics | 2 | 40% |
| Pharmaceutical | 2 | 40% |
| Apps | 1 | 20% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 80% |
| Series B | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 3 | 60% |
| Togo | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| E-nitiate Biopharmaceuticals | E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life. | $14.5M | Series A | Aug 31, 2022 |  |
| Porton Advanced Solutions | Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services. | $80M | Series B | Aug 21, 2022 |  |
| Gozem | Gozem is a transport technology platform for Francophone West and Central Africa. | $5M | Series A | Dec 02, 2021 |  |
| Porton Biologics | Porton Biologics provides end-to-end gene/therapy CDMO service for innovators from the early stage, IND filling, and commercial production. | $56.7M | Series A | Apr 16, 2021 |  |
| Porton Advanced Solutions | Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services. | $61.3M | Series A | Apr 16, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [GL Ventures](https://shizune.co/investors/profile/gl-ventures) — VC Fund, 2 deals together
- [Huatai Ruilian](https://shizune.co/investors/profile/huatai-ruilian-1ce4) — VC Fund, 2 deals together
- [Huimei Capital](https://shizune.co/investors/profile/huimei-capital) — VC Fund, 2 deals together
- [State Development & Investment Corporation](https://shizune.co/investors/profile/state-development-investment-corporation-sdic) — VC Fund, 2 deals together
- [AAIC Holdings](https://shizune.co/investors/profile/aaic-holdings) — VC Fund, 1 deal together
- [Innoport](https://shizune.co/investors/profile/bernhard-schulte-innoport) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [AAIC Holdings](https://shizune.co/investors/profile/aaic-holdings) — VC Fund
- [Century Oak Capital](https://shizune.co/investors/profile/century-oak-capital) — VC Fund
- [UNCOVERED FUND](https://shizune.co/investors/profile/uncovered-fund) — VC Fund

## Featured in investor lists
- [All Investors in Togo](https://shizune.co/investors/investors-togo)
- [All VC Funds in Togo](https://shizune.co/investors/vc-funds-togo)
- [Software VC Funds in Togo](https://shizune.co/investors/software-vc-funds-togo)
- [SaaS Investors in Togo](https://shizune.co/investors/saas-investors-togo)
- [SaaS VC Funds in Togo](https://shizune.co/investors/saas-vc-funds-togo)

## FAQ

### What does Momentum Venture invest in?

Momentum Venture invests primarily in Biotechnology, Genetics and Therapeutics startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Momentum Venture's check size?

Momentum Venture typically joins rounds of $5M–$61M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Momentum Venture participates in.

### When did Momentum Venture last invest?

The most recent investment recorded for Momentum Venture closed in Sep 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co